Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone

Am J Hematol. 2002 Apr;69(4):294-5. doi: 10.1002/ajh.10070.

Abstract

Life-threatening bleeding can occur in non-hemophiliacs with factor VIII inhibitor and is difficult to control. Various methods have been used to suppress the inhibitor. Since 1993 we treated 6 non-hemophilic patients with factor VIII inhibitor with cyclophosphamide, vincristine, and prednisone (CVP) every 3-4 weeks. Five had complete response with disappearance of factor VIII inhibitor and normalization of factor VIII after 1 to 7 cycles of CVP. One patient did not respond after 4 cycles of CVP; mitoxantrone was added to additional two cycles of CVP, and the inhibitor disappeared.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Drug Therapy, Combination
  • Factor VIII / analysis
  • Factor VIII / immunology*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use*
  • Recurrence
  • Remission Induction
  • Vincristine / administration & dosage
  • Vincristine / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Vincristine
  • Cyclophosphamide
  • Factor VIII
  • Prednisone